Government to back Ilyang’s new influenza antiviral drug development

The Transgovernmental Enterprise for Pandemic Influenza in Korea (TEPIK), which was established by the Ministry of Health and Welfare in November 2010, has recently unveiled its plan to sponsor and support Ilyang Pharm’s novel anti-influenza virus drug co-developed by Hallym University.

Under an agreement, the TEPIK will provide subsidies for the company’s preclinical and clinical tests at ...